Skip to main navigation Skip to search Skip to main content

Formulation and characterization of prednisolone compressed lozenges in a low-dose formulation

Research output: Contribution to conference › Poster

5 Downloads (Pure)
Original languageEnglish
Number of pages1
DOIs
Publication statusPublished - 15 Sept 2026
EventConference of the European Paediatric Formulation Initiative - IMLAUER HOTEL PITTER, Rainerstraße 6 , Salzburg, Austria
Duration: 15 Sept 2026 → 17 Sept 2026
Conference number: 18
https://eupfi.co.uk/upcoming-conference/18th-eupfi-conference-2026/#Abstract%20Topics

Conference

ConferenceConference of the European Paediatric Formulation Initiative
Abbreviated titleEuPFI
Country/TerritoryAustria
CitySalzburg
Period15/09/26 → 17/09/26
Internet address

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 9 - Industry, Innovation, and Infrastructure
    SDG 9 Industry, Innovation, and Infrastructure

Keywords*

  • oral dosage forms
  • oral drug delivery
  • compressed lozenges
  • content uniformity
  • Disintegration
  • dissolution

Field of Science

  • 3.1 Basic medicine
  • 1.4 Chemical sciences

Publication Type*

  • 3.4. Other publications in conference proceedings (including local)

Cite this